Peak Processing logo
PKP
Pharmaceuticals, Biotechnology & Life Sciences

Peak Processing

Short interest
0.50%
as of 2 July 2026
Reported shorts
6.7M
Shares on issue
1.329B

Peak Processing (PKP) Short Interest

Peak Processing (ASX:PKP) had 0.50% of shares reported as short positions as of 2 July 2026, representing 6,666,666 shares. Peak Processing operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Price & short interest

About Peak Processing

Company profile →

Peak Processing (ASX:PKP) has 0.50% of its shares on issue reported as short positions as of 2 July 2026, or about 6,666,666 shares. PKP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads PKP today

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

PKP fundamentals

In the year to 30 Jun 2026, Peak Processing (ASX:PKP) recorded revenue of A$12.5M and a net loss after tax of A$7.8M. A year earlier it recorded revenue of A$15.6M and a net loss after tax of A$8.3M. Year-on-year growth: revenue −19.9% (FY). Net margin −62.5% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →

Company details

Company information is being updated. Check back soon.

More Pharmaceuticals, Biotechnology & Life Sciences Stocks

Other shorted stocks in this sector

Be the first to discuss PKP

Start a research thread or post the first pulse update